Systematic Analysis of Gene Expression Alteration and Co-Expression Network of Eukaryotic Initiation Factor 4A-3 in Cancer

Purpose: Eukaryotic initiation factor 4A-3 (EIF4A3) is an RNA-binding protein (RBP) that is a core component of the exon junction complex (EJC). It has been identified as an important player in post-transcriptional regulation processes. Recently, investigations have focused on EIF4A3 dysfunction in carcinogenesis. The present study aims to determine whether EIF4A3 can serve as a prognostic marker and potential regulatory mechanism in human cancers. Materials and methods: EIF4A3 expression in various cancers was assessed using Oncomine. The Correlation between EIF4A3 expression and patient survival was evaluated using PrognoScan. EIF4A3 mutations in various cancers were investigated using cBioPortal. EIF4A3 co-expression networks in various cancers were established using Coexpedia. Finally, we analyzed potential functional roles of EIF4A3 using Gene Ontology and pathway enrichment analyses by FunRich V3. Results: EIF4A3 was overexpressed in common malignancies at the transcription levels. High incidences of the breast, lung, and urinary cancers were closely related to the prognostic index for survival. The most prevalent mutation in EIF4A3 was E59K/Q. The tumor necrosis factor-α (TNF-α)/nuclear factor-κB (NF-κB) signaling pathway was affected by these mutations. Co-expression networks showed that EIF4A3 regulates apoptosis and cell cycle via several cancer-related signal pathways, and promotes tumor cell migration, invasion and drug resistance. Conclusion: Our results suggest the potential role for EIF4A3 to serve as a diagnostic marker or therapeutic target for certain types of cancers.

[1]  Hyojin Kim,et al.  COEXPEDIA: exploring biomedical hypotheses via co-expressions associated with medical subject headings (MeSH) , 2016, Nucleic Acids Res..

[2]  Sherif Abou Elela,et al.  Proteins Associated with the Exon Junction Complex Also Control the Alternative Splicing of Apoptotic Regulators , 2011, Molecular and Cellular Biology.

[3]  F. Pontén,et al.  The Human Protein Atlas as a proteomic resource for biomarker discovery , 2011, Journal of internal medicine.

[4]  Tomoyuki Tsumuraya,et al.  Effects of hippuristanol, an inhibitor of eIF4A, on adult T-cell leukemia. , 2011, Biochemical pharmacology.

[5]  Olivia S. Rissland.  The organization and regulation of mRNA–protein complexes , 2016, Wiley interdisciplinary reviews. RNA.

[6]  Hugues Roest Crollius,et al.  CLIP-seq of eIF4AIII reveals transcriptome-wide mapping of the human exon junction complex , 2012, Nature Structural &Molecular Biology.

[7]  Xu Gao,et al.  Long noncoding RNA H19 indicates a poor prognosis of colorectal cancer and promotes tumor growth by recruiting and binding to eIF4A3 , 2016, Oncotarget.

[8]  Patrick Linder,et al.  From unwinding to clamping — the DEAD box RNA helicase family , 2011, Nature Reviews Molecular Cell Biology.

[9]  Benjamin E. Gross,et al.  Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal , 2013, Science Signaling.

[10]  R. Nusse,et al.  Wnt/β-Catenin Signaling, Disease, and Emerging Therapeutic Modalities , 2017, Cell.

[11]  A. Oberst,et al.  Mitochondrial permeabilisation engages NF-κB dependent anti-tumour activity under caspase deficiency , 2017, Nature Cell Biology.

[12]  Mari Masuda,et al.  Therapeutic targets in the Wnt signaling pathway: Feasibility of targeting TNIK in colorectal cancer. , 2015, Pharmacology & therapeutics.

[13]  W. Wang,et al.  Adrenomedullin protects Leydig cells against lipopolysaccharide-induced oxidative stress and inflammatory reaction via MAPK/NF-κB signalling pathways , 2017, Scientific Reports.

[14]  T. Barrette,et al.  Oncomine 3.0: genes, pathways, and networks in a collection of 18,000 cancer gene expression profiles. , 2007, Neoplasia.

[15]  D. Gordenin,et al.  Somatic mutation load and spectra: A record of DNA damage and repair in healthy human cells , 2018, Environmental and molecular mutagenesis.

[16]  C. Mathers,et al.  Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012 , 2015, International journal of cancer.

[17]  Hongsheng Wang,et al.  Activation of GPER suppresses migration and angiogenesis of triple negative breast cancer via inhibition of NF-κB/IL-6 signals. , 2017, Cancer letters.

[18]  T. Macdonald,et al.  Th17-type cytokines, IL-6 and TNF-α synergistically activate STAT3 and NF-kB to promote colorectal cancer cell growth , 2014, Oncogene.

[19]  Jian Zheng,et al.  LINC00680 and TTN-AS1 Stabilized by EIF4A3 Promoted Malignant Biological Behaviors of Glioblastoma Cells , 2019, Molecular therapy. Nucleic acids.

[20]  K. Nakai,et al.  The Exon Junction Complex Controls the Efficient and Faithful Splicing of a Subset of Transcripts Involved in Mitotic Cell-Cycle Progression , 2016, International journal of molecular sciences.

[21]  Yu Xue,et al.  Phosphoproteomic Analysis of the Highly-Metastatic Hepatocellular Carcinoma Cell Line, MHCC97-H , 2015, International journal of molecular sciences.

[22]  C. Ahn,et al.  A Splicing Variant of NME1 Negatively Regulates NF-κB Signaling and Inhibits Cancer Metastasis by Interacting with IKKβ* , 2014, The Journal of Biological Chemistry.

[23]  M. Moore,et al.  eIF4AIII binds spliced mRNA in the exon junction complex and is essential for nonsense-mediated decay , 2004, Nature Structural &Molecular Biology.

[24]  Anne-Marie Alleaume,et al.  Exon Junction Complexes Show a Distributional Bias toward Alternatively Spliced mRNAs and against mRNAs Coding for Ribosomal Proteins , 2016, Cell reports.

[25]  P. Linder,et al.  DEAD-box proteins: the driving forces behind RNA metabolism , 2004, Nature Reviews Molecular Cell Biology.

[26]  Kenta Nakai,et al.  PrognoScan: a new database for meta-analysis of the prognostic value of genes , 2009, BMC Medical Genomics.

[27]  Masahiro Ito,et al.  Discovery of Novel 1,4-Diacylpiperazines as Selective and Cell-Active eIF4A3 Inhibitors. , 2017, Journal of medicinal chemistry.

[28]  M. Hentze,et al.  Disassembly of Exon Junction Complexes by PYM , 2009, Cell.

[29]  Qinghua Zhao,et al.  Sanguinarine inhibits epithelial ovarian cancer development via regulating long non-coding RNA CASC2-EIF4A3 axis and/or inhibiting NF-κB signaling or PI3K/AKT/mTOR pathway. , 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[30]  D. Gatfield,et al.  An eIF4AIII-containing complex required for mRNA localization and nonsense-mediated mRNA decay , 2004, Nature.

[31]  Hui Zhou,et al.  starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein–RNA interaction networks from large-scale CLIP-Seq data , 2013, Nucleic Acids Res..

[32]  Ching-Seng Ang,et al.  FunRich: An open access standalone functional enrichment and interaction network analysis tool , 2015, Proteomics.